Explore ESSA Pharma Inc.'s financial standing as of Dec 31, 2024. With no revenue and legal challenges, a 'Hold' recommendation is advised for investors.
Explore ESSA Pharma Inc.'s 8-K filing from February 11, 2025, detailing corporate changes and share info. Learn about the company's compliance and financial updates.
Explore ESSA Pharma Inc.'s financial performance, stock recommendation, and market challenges. Key insights on liquidity, clinical trial setbacks, and future outlook for investors.
Discover essential updates from ESSA Pharma Inc.'s December 2024 8-K filing. Key insights on stock performance, corporate governance, and recent developments for investors.